1 Botelho AFM, Pierezan F, Soto-Blanco B, Melo MM: A review of cardiac glycosides: Structure, toxicokinetics, clinical signs, diagnosis and antineoplastic potential. Toxicon. 2019;158:63–8.
2 O’Malley CM, Frumento RJ, Hardy MA, Benvenisty AI, Brentjens TE, Mercer JS, Bennett-Guerrero E: A randomized, double-blind comparison of lactated Ringer’s solution and 0,9% NaCl during renal transplantation. Anesth Analg. 2005:100(5):1518–24, table of contents.
3 Khajavi MR, Etezadi F, Moharari RS, Imani F, Meysamie AP, Khashayar P, Najafi A: Effects of normal saline vs. lactated ringer’s during renal transplantation. Ren Fail. 2008;30(5):535–9.
4 Modi MP, Vora KS, Parikh GP, Shah VR: A comparative study of impact of infusion of Ringer’s Lactate solution versus normal saline on acid-base balance and serum electrolytes during live related renal transplantation. Saudi J Kidney Dis Transpl. 2012;23(1):135–7.
5 Kalkut G: Sulfonamides and trimethoprim. Cancer Invest. 1998;16(8):612–5.
6 Gleckman R, Blagg N, Joubert DW: Trimethoprim: mechanisms of action, antimicrobial activity, bacterial resistance, pharmacokinetics, adverse reactions, and therapeutic indications. Pharmacotherapy. 1981;1(1):14–20.
7 Masters PA, O’Bryan TA, Zurlo J, Miller DQ, Joshi N: Trimethoprim-sulfamethoxazole revisited. Archives of internal medicine. 2003;163(4):402–10.
8 Nigam SK, Wu W, Bush KT, Hoenig MP, Blantz RC, Bhatnagar V: Handling of Drugs, Metabolites, and Uremic Toxins by Kidney Proximal Tubule Drug Transporters. Clin J Am Soc Nephrol. 2015;10(11):2039–49.
9 Eiam-Ong S, Kurtzman NA, Sabatini S: Studies on the mechanism of trimethoprim-induced hyperkalemia. Kidney Int. 1996;49(5):1372–8.
10 Velazquez H, Perazella MA, Wright FS, Ellison DH: Renal mechanism of trimethoprim-induced hyperkalemia. Ann Intern Med. 1993;119(4):296–301.
11 Reinalter SC, Jeck N, Peters M, Seyberth HW: Pharmacotyping of hypokalaemic salt-losing tubular disorders. Acta Physiol Scand. 2004;181(4):513–21.
12 Antoniou T, Gomes T, Juurlink DN, Loutfy MR, Glazier RH, Mamdani MM: Trimethoprim-sulfamethoxazole-induced hyperkalemia in patients receiving inhibitors of the renin-angiotensin system: a population-based study. Archives of internal medicine. 2010;170(12):1045–9.
13 Crellin E, Mansfield KE, Leyrat C, Nitsch D, Douglas IJ, Root A, Williamson E, Smeeth L, Tomlinson LA: Trimethoprim use for urinary tract infection and risk of adverse outcomes in older patients: cohort study. BMJ. 2018;360:k341.